The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. We collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients.
Jay Bradner, M.D., is president of the Novartis Institutes for BioMedical Research. A physician-scientist, he focuses on discovery and early development of definitive therapies for serious diseases. Follow Jay: Twitter | LinkedIn
The research institutes of the NIBR network are located across the globe to gain access to the world's best scientific talent. This network of institutes maintains a highly collaborative culture that encourages teams and individuals to work across institutional and geographic boundaries.
Novartis Institutes for BioMedical Research (NIBR) accepts a broader responsibility to society by supporting the communities around us and around the world.
We give back to society through direct contributions to organizations that advance science education, diversity and healthy living.
Nonprofit and other grant seeking organizations with approved tax-exempt status, particularly those located near a NIBR campus, are welcome to apply through our online database NIBR Giving. Please note, this site is intended for U.S. organizations.
Community Exploration & Learning Lab (CELL)
NIBR programs, such as CELL (the Community Exploration & Learning Lab) in Cambridge, Mass, U.S., build students’ confidence through hands-on experimentation and minds-on problem solving.
Find opportunities to gain hands-on experience in a variety of research programs at Novartis.
The Postbaccalaureate Scholars Program at NIBR is an accelerated experience for talented scholars from under resourced communities. Students interested in the Postbaccalaureate Scholars Program can find more information here.
Our programs are designed to introduce talented students to drug discovery and to offer rigorous research training in this area.